{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:50:44Z","timestamp":1780671044811,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008682","name":"Boston VA Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008682","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002736","name":"Covidien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.atherosclerosis.2012.08.025","type":"journal-article","created":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T12:09:57Z","timestamp":1346328597000},"page":"91-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Endothelial progenitor cell response to antiproliferative drug exposure"],"prefix":"10.1016","volume":"225","author":[{"given":"Subhash","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Fuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kytai T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil S.","family":"Brilakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib1","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.CIR.0000163587.36485.A7","article-title":"Molecular basis of restenosis and drug-eluting stents","volume":"111","author":"Costa","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.amjmed.2006.01.023","article-title":"Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials","volume":"119","author":"Bavry","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib4","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/S0140-6736(08)60922-8","article-title":"Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis","volume":"371","author":"Bavry","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib5","first-page":"674","article-title":"Late stent thrombosis after drug-eluting stent implantation: epidemiological, clinical and pathophysiological aspects","volume":"9","author":"Notaristefano","year":"2008","journal-title":"G\u00a0Ital Cardiol (Rome)"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jacc.2008.04.030","article-title":"Endothelial cell recovery between comparator polymer-based drug-eluting stents","volume":"52","author":"Joner","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2008.02.091","article-title":"Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation","volume":"102","author":"Xie","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00029330-200803020-00005","article-title":"Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography","volume":"121","author":"Yao","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib10","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib11","doi-asserted-by":"crossref","first-page":"k32","DOI":"10.4244\/EIJV7SKA6","article-title":"Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells","volume":"7","author":"Clever","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib12","first-page":"203","article-title":"Very late bare-metal stent thrombosis. A case report and review of the literature","volume":"18","author":"Manjappan","year":"2006","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.atherosclerosis.2006.04.026","article-title":"Endothelial progenitor cell mobilization after percutaneous coronary intervention","volume":"189","author":"Banerjee","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib14","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2337\/db06-1103","article-title":"High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms","volume":"56","author":"Chen","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.addr.2006.01.023","article-title":"The Taxus drug-eluting stent: a new paradigm in controlled drug delivery","volume":"58","author":"Kamath","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2005.09.042","article-title":"Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries","volume":"524","author":"Parry","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-59745-571-8_1","article-title":"Rat carotid artery balloon injury model","volume":"139","author":"Tulis","year":"2007","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrd2466","article-title":"The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics","volume":"7","author":"Lundberg","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1114\/1.1349700","article-title":"Shear stress reduces protease activated receptor-1 expression in human endothelial cells","volume":"29","author":"Nguyen","year":"2001","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib20","first-page":"567","article-title":"Polymer coatings and delayed arterial healing following drug-eluting stent implantation","volume":"57","author":"Byrne","year":"2009","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1253\/circj.CJ-09-0546","article-title":"Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation","volume":"74","author":"Kim","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib22","doi-asserted-by":"crossref","first-page":"36M","DOI":"10.1016\/j.amjcard.2007.08.020","article-title":"The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents","volume":"100","author":"Nakazawa","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib23","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jcin.2010.04.005","article-title":"Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study","volume":"3","author":"Guagliumi","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib24","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib25","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(87)91481-4","article-title":"Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium","volume":"2","author":"Radomski","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0031-6997(25)06759-6","article-title":"Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin","volume":"30","author":"Moncada","year":"1979","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0006-291X(85)90615-1","article-title":"Heparin-like molecules with anti-coagulant activity are synthesized by cultured endothelial cell","volume":"126","author":"Marcum","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-0038-1653397","article-title":"Antithrombin III, the major modulator of intravascular coagulation, is synthesized by human endothelial cells","volume":"46","author":"Chan","year":"1981","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib29","doi-asserted-by":"crossref","first-page":"12238","DOI":"10.1016\/S0021-9258(17)44163-9","article-title":"Thrombomodulin blocks the ability of thrombin to activate platelets","volume":"258","author":"Esmon","year":"1983","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2012.08.025_bib30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ijc.20595","article-title":"Increased endothelial uptake of paclitaxel as a potential mechanism for its antiangiogenic effects: potentiation by Cox-2 inhibition","volume":"113","author":"Merchan","year":"2005","journal-title":"Int J Cancer"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012005746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012005746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:22:14Z","timestamp":1762186934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915012005746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0021915012005746"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.08.025","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial progenitor cell response to antiproliferative drug exposure","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}